Sean Grant
2021
In 2021, Sean Grant earned a total compensation of $2.1M as Chief Financial Officer at Vera Therapeutics.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Non-Equity Incentive Plan | $67,858 |
| Option Awards | $1,765,026 |
| Salary | $189,487 |
| Total | $2,082,371 |
Grant received $1.8M in option awards, accounting for 85% of the total pay in 2021.
Grant also received $60K in bonus, $67.9K in non-equity incentive plan and $189.5K in salary.
Rankings
In 2021, Sean Grant's compensation ranked 5,898th out of 12,406 executives tracked by ExecPay. In other words, Grant earned more than 52.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,898 out of 12,406 | 53rd |
Division Manufacturing | 2,491 out of 5,492 | 55th |
Major group Chemicals And Allied Products | 1,082 out of 2,368 | 54th |
Industry group Drugs | 963 out of 2,089 | 54th |
Industry Pharmaceutical Preparations | 692 out of 1,536 | 55th |
Source: SEC filing on April 14, 2022.
Grant's colleagues
We found two more compensation records of executives who worked with Sean Grant at Vera Therapeutics in 2021.